Pfizer Board of Directors: James C. Smith, Age: 57
President and Chief Executive Officer of Thomson Reuters Corporation, the world's leading source of intelligent information for businesses and professionals, since January 2012, its Chief Operating Officer from September 2011 to December 2011, and its Chief Executive Officer, Thomson Reuters Professional Division, from 2008 to 2011. Prior to the acquisition of Reuters Group PLC (Reuters) by The Thomson Corporation (Thomson) in 2008, he served as Chief Operating Officer of Thomson and as President and Chief Executive Officer of Thomson Learning's Academic and Reference Group. He began his career as a journalist and rose through the ranks at the Thomson Newspaper Group, which he joined in 1987, to become the head of its North America operations. With the sale of the Thomson Newspaper Group in 2000, he joined Thomson as Executive Vice President in 2001. Currently, he is a member of the International Business Council of the World Economic Forum, the International Advisory Boards of British American Business and the Atlantic Council. Our Director since 2014. Chair of our Compensation Committee and member of our Audit and Science and Technology Committees.
Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration from 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute, a partner at the venture capital firm New Enterprise Associates, a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., a contributor to the cable financial news network CNBC, and a frequent guest on the CBS News program Face the Nation. He is the author of the The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. Before becoming FDA commissioner, he was a clinical assistant professor at New York University School of Medicine, the FDA deputy commissioner for medical and scientific affairs, a venture partner with New Enterprise Associates, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare and Medicaid Services, and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017 prior to joining the FDA as commissioner in May 2017.
www.pfizer.com
Hahn, who served as the FDA head in former President Trump's administration, oversaw the emergency use authorization of the Moderna COVID-19 vaccine in December.
Fauci has a long list of crap to include his wife in the NIH.
I wonder how their positions and prior positions played into this? No conflict of interest going on here at all